New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - ceftriaxone sodium 269.9mg (present as 0.298g ceftriaxone na*3.5h2o. eq 0.269g of ceftriaxone na anhyd or 0.25g ceftriaxone anhy) - powder for injection - 250 mg - active: ceftriaxone sodium 269.9mg (present as 0.298g ceftriaxone na*3.5h2o. eq 0.269g of ceftriaxone na anhyd or 0.25g ceftriaxone anhy)

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - ceftriaxone sodium 2158.6mg (present as 2.386g ceftriaxone na*3.5h2o. eq 2.158g of ceftriaxone na anhyd or 2g ceftriaxone anhyd) - powder for injection - 2 g - active: ceftriaxone sodium 2158.6mg (present as 2.386g ceftriaxone na*3.5h2o. eq 2.158g of ceftriaxone na anhyd or 2g ceftriaxone anhyd)

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - ceftriaxone sodium 539.65mg (present as 0.5965g ceftriaxone na*3.5h2o. eq 0.53965g of ceftriaxone na anh or 0.5g ceftriaxone anh) - powder for injection - 500 mg - active: ceftriaxone sodium 539.65mg (present as 0.5965g ceftriaxone na*3.5h2o. eq 0.53965g of ceftriaxone na anh or 0.5g ceftriaxone anh)

Canada - English - Health Canada

baxter corporation - ceftriaxone (ceftriaxone sodium) - solution - 1000mg - ceftriaxone (ceftriaxone sodium) 1000mg - third generation cephalosporins

Canada - English - Health Canada

baxter corporation - ceftriaxone (ceftriaxone sodium) - solution - 2000mg - ceftriaxone (ceftriaxone sodium) 2000mg - third generation cephalosporins

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - ceftriaxone sodium (unii: 023z5br09k) (ceftriaxone - unii:75j73v1629) - before instituting treatment with ceftriaxone for injection, usp appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. therapy may be instituted prior to obtaining results of susceptibility testing. to reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone for injection, usp and other antibacterial drugs, ceftriaxone for injection, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. ceftriaxone for injection, usp is indicated for the treatment of the following infections when caused by susceptible organisms: lower respiratory tract infections caused b

United States - English - NLM (National Library of Medicine)

sagent pharmaceuticals - ceftriaxone sodium (unii: 023z5br09k) (ceftriaxone - unii:75j73v1629) - before instituting treatment with ceftriaxone for injection, usp, appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. therapy may be instituted prior to obtaining results of susceptibility testing. to reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone for injection, usp and other antibacterial drugs, ceftriaxone for injection, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. ceftriaxone for injection, usp is indicated for the treatment of the following infections when caused by susceptible organisms: lower respiratory tract infections caused

Malta - English - Medicines Authority

pharmsol europe limited the victoria centre unit 2, lower ground floor, valletta road, mosta mst 9012 , malta - ceftriaxone - powder for solution for injection/infusion - ceftriaxone 1000 mg - antibacterials for systemic use

United States - English - NLM (National Library of Medicine)

general injectables and vaccines, inc. - ceftriaxone sodium (unii: 023z5br09k) (ceftriaxone - unii:75j73v1629) - before instituting treatment with ceftriaxone for injection, usp, appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. therapy may be instituted prior to obtaining results of susceptibility testing. to reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone for injection, usp and other antibacterial drugs, ceftriaxone for injection, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. ceftriaxone for injection, usp is indicated for the treatment of the following infections when caused by susceptible organisms: lower respiratory tract infections caused b

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

reyoung pharmaceutical co. ltd. - ceftriaxone (ceftriaxone sodium) - powder for solution for i/m and i/v injection - 1000mg